Literature DB >> 24920352

Association between the lengths of GT dinucleotide repeat in the PIK3CA gene with breast cancer risk.

Najmeh Heshmatpour1, Simin Hematti, Seyyed Hossein Hejazi, Forousan Safari, Manoochehr Tavassoli.   

Abstract

The phosphatidylinositol 3-kinase (PI3 K)/Akt signaling pathway is one of the most commonly mutated pathways in breast cancer. To date, there has been no study on polymorphism of phosphatidylinositol-3,4-bisphosphonate 3-kinase, catalytic subunit alpha (PIK3CA) gene microsatellites and their link with breast cancer risk. In the present study, we investigate the guanine-thymine (GT) dinucleotide repeat polymorphism in intron 1 of PIK3CA gene in a cohort of 200 breast cancer patients and 200 healthy individuals and its link to the risk of developing breast cancer. The results of this study demonstrate that PIK3CA gene allele distribution in Isfahan population varies between 13 and 20 repeats. GT14 and GT16 were the most common allele present in patients, and GT17 was the most common allele in controls. Women with one or two alleles shorter than 17 GT repeat have a significantly higher risk of developing breast cancer [Odds ratio (OR) 3.6, p = 0.00001 and OR 3.98, p = 0.000001, respectively], in contrast, women with one or two alleles longer than 16 are at lower risk of breast cancer. This result suggests a potential role for this microsatellite as a predictive marker of breast cancer risk in Iranian women.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24920352     DOI: 10.1007/s12032-014-0029-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  22 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Breast cancer in the world: incidence and mortality.

Authors:  María Paula Curado
Journal:  Salud Publica Mex       Date:  2011 Sep-Oct

4.  Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.

Authors:  S A Chrysogelos
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

5.  Non-invasive imaging of PI3K/Akt/mTOR signalling in cancer.

Authors:  Snehal M Gaikwad; Pritha Ray
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

6.  Reproductive characteristics and the risk of breast cancer--a case-control study in Iran.

Authors:  P Yavari; M Mosavizadeh; B Sadrol-Hefazi; Y Mehrabi
Journal:  Asian Pac J Cancer Prev       Date:  2005 Jul-Sep

7.  Breast cancer in Iran: results of a multi-center study.

Authors:  Iraj Harirchi; Mojgan Karbakhsh; Amir Kashefi; Amir Javad Momtahen
Journal:  Asian Pac J Cancer Prev       Date:  2004 Jan-Mar

Review 8.  Breast cancer in Iran: an epidemiological review.

Authors:  Seyed Mohsen Mousavi; Ali Montazeri; Mohammad Ali Mohagheghi; Alireza Mousavi Jarrahi; Iraj Harirchi; Masomeh Najafi; Mandana Ebrahimi
Journal:  Breast J       Date:  2007 Jul-Aug       Impact factor: 2.431

9.  Expression of the human PDGF-B gene is regulated by both positively and negatively acting cell type-specific regulatory elements located in the first intron.

Authors:  G C Franklin; M Donovan; G I Adam; L Holmgren; S Pfeifer-Ohlsson; R Ohlsson
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

10.  CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity.

Authors:  A K Agarwal; G Giacchetti; G Lavery; H Nikkila; M Palermo; M Ricketts; C McTernan; G Bianchi; P Manunta; P Strazzullo; F Mantero; P C White; P M Stewart
Journal:  Hypertension       Date:  2000-08       Impact factor: 10.190

View more
  1 in total

Review 1.  Genetic and molecular biology of breast cancer among Iranian patients.

Authors:  Meysam Moghbeli
Journal:  J Transl Med       Date:  2019-07-08       Impact factor: 5.531

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.